Covered recipient · General Payments record
MIRA SCHARFF
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$963.54
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $394.04 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $166.78 | 3 |
| Amgen Inc. | $121.87 | 1 |
| Lilly USA, LLC | $25.32 | 1 |
| Alkermes, Inc. | $22.22 | 1 |
| ABBVIE INC. | $20.60 | 1 |
| ITI, Inc. | $18.92 | 1 |
| Acerta Pharma LLC | $18.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.60 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108152429 | CMS |
| Alkermes, Inc. | $22.22 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120592815 | CMS |
| Amgen Inc. | $121.87 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117375733 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.33 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105379783 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.92 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143599371 | CMS |
| Lilly USA, LLC | $25.32 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135871784 | CMS |
| Novo Nordisk Inc | $17.36 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100485377 | CMS |
| Novo Nordisk Inc | $23.53 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100226586 | CMS |
| Novo Nordisk Inc | $125.89 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100653489 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.